Perfect CUP and HANDLE structure, massive potential upside!!

Analysts have a price target between $2 and $3.
Earnings report on 17 Feb 2021.

They launch their first FDA-approved product Vyleesi to market in Q3 of 2020 which could potentially help 6 million women suffering from HSDD in the USA alone. This product generated $800 million in sales in Q3 and will grow over time as Palatin is currently the only company offering medicine for HSDD on the market.
Also, they have a second potential billion-dollar product in the pipeline that could hit the market in 2021 which treats DED and has 16 million cases in the USA.

As of June 30, 2020, the Company had $82.9 million in cash and cash equivalents, compared to $43.5 million as of June 30, 2019, and no debt.
Their short-term liabilities are on average around €5 million.

Besides this, the chart looks very bullish as it shows an almost perfect CUP and HANDLE structure. Giving the current mania in the market I wouldn't be surprised if this blows up after some positive news from their earnings report on 17 Feb.

I am not a financial advisor, always do your own due diligence before buying any stock.
This stock could potentially drop -50%, always add a stop-loss in penny stocks like this.